Scarletred

🎗️ May is about 🔊

🔬 Skin cancer is one of the most common cancer groups in modern civilization - and one of the most preventable.

Prevention requires more than sunscreen. It demands verified clinical information, objective documentation, and consistent monitoring over time.

📌 A few facts:

In Europe, 7.3 million people are affected - with incidence projected to rise by 34% by 2040.
In the U.S., 1 in 5 Americans is likely to develop skin cancer by age 70.
In Australia and New Zealand, 2 in 3 are likely to be diagnosed in their lifetime.

🔎 Early detection changes outcomes. That is why Scarletred®Vision enables objective, AI-powered skin lesion documentation, quantification, and longitudinal monitoring.

Emerging research goes even further: A monocentric study at the Hospital of Wiener Neustadt is currently investigating whether iris pigmentation may be a predictor for basal cell carcinoma risk - using Scarletred®Vision, powered by ®AI.

👉 Swipe through our gallery to find out more!

🔬 Building the future of clinical research in Austria 🔬

had the privilege of joining Medical University of Vienna (MedUni Wien) for the official presentation of its New Clinical Research Hub:

💡The Center for Translational Medicine (CTM) and the Eric Kandel Institute – Center for Precision Medicine (CPM).

Thank you for your warm welcome Markus Zeitlinger, Head of Department of Clinical Pharmacology of MedUni Vienna, and Agnes Bugajska-Schretter!

🤝 This invitation reflects a strong and growing collaboration. Over the past years, we have worked together on impactful research projects:

🌟 From medical device studies on the sensitivity and specificity of SARS-CoV-2 rapid antigen tests
🌟 to a first in human Phase Ib trial, validating safety of subcutaneous recombinant Human Superoxide Dismutase (rhSOD) by integrating Artificial Intelligence.

What’s emerging now at the Medical University of Vienna goes far beyond infrastructure:

📍 A new campus designed to bring research, clinical practice, and education closer together - accelerating the translation from lab to patient and fostering data-driven medicine.

🔬 With dedicated spaces such as the CTM and the CPM and a strong focus on interdisciplinary innovation, this development marks a significant step for Austria’s clinical research landscape.

We are proud to contribute to this momentum and look forward to expanding collaboration opportunities 🤝

🔗 Read more about our collaborative research on our website.

SCARLETRED joins MedUni Wien for presentation of New Clinical Research Hub SCARLETRED was invited by MedUni Wien to the presentation of its new clinical research hub: the Center for Translational Medicine (CTM) and the Eric Kandel Institute - Center for Precision Medicine (CPM).